LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Search

Zimmer Biomet Holdings Inc

Closed

SectorHealthcare

83.67 1.3

Overview

Share price change

24h

Current

Min

82.47

Max

84.22

Key metrics

By Trading Economics

Income

99M

239M

Sales

-157M

2.1B

P/E

Sector Avg

20.617

51.415

EPS

2.09

Dividend yield

1.17

Profit margin

11.43

Employees

17,000

EBITDA

84M

538M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+17.36% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.17%

2.34%

Next Earnings

6 Aug 2026

Next Dividend date

30 Jul 2026

Next Ex Dividend date

25 Jun 2026

Market Stats

By TradingEconomics

Market Cap

-2.5B

15B

Previous open

82.37

Previous close

83.67

News Sentiment

By Acuity

8%

92%

4 / 346 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Zimmer Biomet Holdings Inc Chart

Past performance is not a reliable indicator of future results.

Related News

5 Nov 2025, 19:38 UTC

Earnings

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5 Nov 2025, 17:00 UTC

Earnings

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

Peer Comparison

Price change

Zimmer Biomet Holdings Inc Forecast

Price Target

By TipRanks

17.36% upside

12 Months Forecast

Average 97.08 USD  17.36%

High 109 USD

Low 83 USD

Based on 16 Wall Street analysts offering 12 month price targets forZimmer Biomet Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

16 ratings

4

Buy

11

Hold

1

Sell

Technical Score

By Trading Central

92.27 / 100.88Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

4 / 346 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.
help-icon Live chat